Boston Scientific is spending $14.5 billion in cash and stock to buy Penumbra, another medical-device maker that makes ...

Boston Scientific Corporation (NYSE: BSX) and Penumbra, Inc., (NYSE: PEN) today announced the companies have entered into a ...

The Farapoint device adds another tool to the company’s pulsed field ablation portfolio that could help increase or sustain ...

Boston Scientific’s last mega-deal didn’t go so well. The medtech company with a large Minnesota presence acquired Arden ...

In a significant move within the medtech industry, Boston Scientific announced on Thursday its intention to acquire Penumbra for approximately $14.5 billion. This acquisition aims to enhance Boston ...

Boston Scientific is buying up privately owned medtech Valencia Technologies for its implantable device aimed at helping ...

Boston Scientific said on Thursday it will buy medtech firm Penumbra in a deal valued at about US$14.5 billion to expand its ...

Boston Scientific has agreed to acquire Penumbra in a deal worth about $14.5 billion. Boston Scientific has agreed to acquire ...

Boston Scientific (NYSE: BSX) announced that it received CE mark approval for its Embold detachable coil system.

Boston Scientific has enjoyed success in the cardiac device space, but it continues to look to gain market share elsewhere, ...

In recent days, Boston Scientific has drawn upbeat commentary from Wall Street, with analysts citing strong demand across ...